Heart and Vascular
PROACTIVE-HF-2
Heart Failure
A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II -III Heart Failure Patients (PROACTIVE- HF-2 Trial)
Contact Research Team:
[email protected]
Site principal investigator:
Michael Nassif, MD
Learn more about this study:
NCT05934487